Non-invasive Measurements of Bone Strength: Promise and Peril
Overview
Authors
Affiliations
Chronic kidney disease and the skeleton.
Miller P Bone Res. 2015; 2:14044.
PMID: 26273531 PMC: 4472138. DOI: 10.1038/boneres.2014.44.
Bisphophonates in CKD patients with low bone mineral density.
Liu W, Yen J, Lang C, Yan M, Lu K ScientificWorldJournal. 2014; 2013:837573.
PMID: 24501586 PMC: 3899701. DOI: 10.1155/2013/837573.
Fracture risk assessment in patients with chronic kidney disease.
Jamal S, West S, Miller P Osteoporos Int. 2011; 23(4):1191-8.
PMID: 21901475 DOI: 10.1007/s00198-011-1781-0.
Effect of monthly ibandronate on hip structural geometry in men with low bone density.
Genant H, Lewiecki E, Fuerst T, Fries M Osteoporos Int. 2011; 23(1):257-65.
PMID: 21811866 DOI: 10.1007/s00198-011-1732-9.
Infrared imaging microscopy of bone: illustrations from a mouse model of Fabry disease.
Boskey A, Goldberg M, Kulkarni A, Gomez S Biochim Biophys Acta. 2006; 1758(7):942-7.
PMID: 16697974 PMC: 1551908. DOI: 10.1016/j.bbamem.2006.02.019.